Skip to content
Search

Latest Stories

'Holmes is not a villain, but her company failed,' defense says during Theranos trial

'Holmes is not a villain, but her company failed,' defense says during Theranos trial

THERANOS founder Elizabeth Holmes is not a villain but rather a hard-working, young and naive businesswoman whose company simply failed, her lawyer told jurors on Wednesday (8) at the former Silicon Valley star's trial on fraud charges involving the now-defunct blood-testing startup once valued at $9 billion.

Federal prosecutors and defense lawyers painted remarkably different portraits of Holmes in their opening statements to the 12-member jury in one of the most closely watched trials of an American corporate executive in years. The prosecution then called its first witness, a former company executive.


Robert Leach, one of the prosecutors, said Holmes had engaged in a scheme of "lying and cheating" to attain wealth and fame at the expense of investors and patients.

Holmes is accused of making false claims about Theranos, including that its devices - designed to draw a drop of blood from a finger prick - could run a range of tests more quickly and accurately than conventional laboratory means.

"In the end, Theranos failed and Holmes walked away with nothing," defense lawyer Lance Wade told jurors in San Jose, California.

"But failure is not a crime. Trying your hardest and coming up short is not a crime. And by the time this trial is over, you will see that the villain the government just presented is actually a living, breathing human being who did her very best each and every day. And she is innocent," Wade added.

Holmes, 37, has pleaded not guilty to 10 counts of wire fraud and two counts of conspiracy. She may testify during the trial, which resumes on Friday (10) with more witness testimony.

"This is a case about fraud - about lying and cheating to get money," prosecutor Leach told jurors.

"The scheme brought her fame, it brought her honour and it brought her adoration," Leach added, also making her a billionaire.

"She had become, as she sought, one of the most celebrated CEOs in Silicon Valley and the world. But under the facade of Theranos' success there were significant problems brewing," Leach said.

The defense disagreed. Wade told jurors: "Elizabeth Holmes did not go to work every day intending to lie, cheat and steal. The government would have you believe her company, her entire life, is a fraud. That is wrong."

On paper, Theranos was worth billions of dollars, but when Holmes left it in 2018, her savings, stock and company were "all gone," Wade said.

Wade asked jurors to ponder whether Theranos failed because its technology was a fraud or "because a young CEO and her company confronted and could not overcome business obstacles that others saw but she naively underestimated."

Wade said Holmes dropped out of prestigious Stanford University at age 19 and bet her savings to start Theranos in 2003, then poured her life into it for 15 years. Holmes grabbed headlines with her vision of a small machine that could run blood tests in stores and homes.

"She was all in on Theranos, motivated by its mission, not money, committed to that mission until that very last day," Wade said.

Former Theranos executive Ramesh "Sunny" Balwani, scheduled to be tried separately, also has pleaded not guilty. Court filings showed that Holmes, who had a romantic relationship with Balwani, has said he abused her emotionally and psychologically - allegations he denies.

One of her mistakes, Wade told jurors, was "trusting and relying on Balwani as her primary adviser."

Prosecutors have said Holmes and Balwani defrauded investors between 2010 and 2015 and deceived patients when Theranos began making its tests commercially available, including a partnership with the Walgreens drugstore chain.

Leach said Holmes agreed with Balwani to carry out the scheme. In 2009, after losing interest from Pfizer Inc and other pharmaceutical companies, Holmes turned to fraud, Leach said.

"Out of time and out of money, Elizabeth Holmes decided to lie," Leach said.

(Reuters)

More For You

CSK vs RCB

CSK and RCB-tune in for this blockbuster clash between two IPL heavyweights

Getty Images

IPL 2025 - CSK vs RCB: Chennai and Bengaluru's clash of titans

The Indian Premier League (IPL) is back with another highly anticipated encounter as Chennai Super Kings (CSK) lock horns with Royal Challengers Bengaluru (RCB) in the 8th match of the 2025 season. The match will take place at the iconic MA Chidambaram Stadium in Chennai on March 28th at 7:30 PM IST. Both teams are coming off strong wins in their previous matches and are eager to extend their winning streaks, making this clash one that fans won’t want to miss.

Team analysis: Chennai Super Kings (CSK)

CSK, one of the most successful franchises in IPL history, comes into this game with confidence after a thrilling victory over Mumbai Indians. Although the chase wasn’t entirely smooth, CSK managed to pull off a win with 4 wickets in hand. Their bowling unit, led by the young sensation Noor Ahmad, was instrumental in restricting Mumbai to a modest total of 155/9. Noor’s outstanding spell of 4 wickets for just 18 runs earned him the well-deserved Man of the Match title, while Khaleel Ahmed also chipped in with 3 wickets.

Keep ReadingShow less
Streeting: Health deal signals new era in UK-India ties

Foreign Office minister Catherine West, health secretary Wes Streeting and equalities minister Seema Malhotra during the Holi Reception in London.

Streeting: Health deal signals new era in UK-India ties

THE recent health and life sciences agreement between the UK and India will strengthen cooperation on healthcare innovation and security in both countries, health secretary Wes Streeting said.

Speaking at the Holi reception organised by the India All-Party Parliamentary Group and the 1928 Institute in London on Monday (24), he added that the contribution of British Indians has been pivotal in the growth of the NHS since its inception in 1948, and a robust partnership between the two nations will ensure we have a healthcare provider 'fit for the future'.

Keep ReadingShow less
Renée Zellweger Joins Only Murders in the Building Season 5 Cast

Renée Zellweger joins the cast of Only Murders in the Building Season 5, bringing more star power to the hit series

Getty Images

Renée Zellweger joins ‘Only Murders in the Building’ season 5 with an expanded star-studded cast

The Oscar-winning actress joins Steve Martin, Selena Gomez, and Martin Short in Hulu’s hit mystery-comedy for an exciting new season.

Renée Zellweger is the latest Hollywood star to join Hulu's hit mystery-comedy Only Murders in the Building for its fifth season. The two-time Academy Award winner will share the screen with series regulars Steve Martin, Martin Short, and Selena Gomez, adding to the show’s already impressive line-up of guest stars.

Keep ReadingShow less
british-steel-iStock

An aerial view of Steel Plant Industry in Scunthorpe. (Photo: iStock)

British Steel to shut blast furnaces, up to 2,700 jobs at risk

BRITISH STEEL, owned by Chinese group Jingye, confirmed on Thursday that it will shut down its blast furnaces and steelmaking operations in England, attributing the decision to market challenges, tariffs, and rising environmental costs.

The closures, first proposed in late 2023, could lead to the loss of up to 2,700 jobs at the company’s main UK site in Scunthorpe, northern England, according to sources familiar with the matter.

Keep ReadingShow less